Li Na Ma

Li Na Ma

Chief Executive Officer at
Staidson Hong Kong Investment Co. Ltd.
50 year
Health Technology
Consumer Services
Finance

Profile

Li Na Ma is Chief Executive Officer at Staidson Hong Kong Investment Co. Ltd. since 2015.
Ms. Ma is Chairman at Beijing Defengrei Biotechnology Co. Ltd. since 2015.
Ms. Ma is General Manager at Zhejiang Staidson Investment Co., Ltd. since 2017.
Ms. Ma is Secretary at Staidson Biopharma, Inc. since 2013.
Former positions include Director at InflaRx GmbH, Secretary, Director & Deputy General Manager at Staidson (Beijing) Biopharmaceuticals Co., Ltd. from 2018 to 2021, Non-Executive Director at InflaRx NV, Secretary & Deputy General Manager at Sichuan Huiyu Pharmaceutical Co., Ltd. in 2023, and General Manager at JOINN Laboratories (China) Co., Ltd. from 2002 to 2009.
Education includes an MBA from HKU School of Professional & Continuing Education and an undergraduate degree from Hunan University of Chinese Medicine.

Li Na Ma active positions

CompaniesPositionStart
Beijing Defengrei Biotechnology Co. Ltd.
Chairman 31/08/2015
Corporate Secretary 31/12/2012
Chief Executive Officer 31/12/2014
Chief Executive Officer 31/05/2017

Former positions of Li Na Ma

CompaniesPositionEnd
STAIDSON (BEIJING) BIOPHARMACEUTICALS CO., LTD. Director/Board Member 30/12/2021
JOINN LABORATORIES(CHINA)CO.,LTD. Corporate Officer/Principal 31/12/2008
SICHUAN HUIYU PHARMACEUTICAL CO., LTD. Director/Board Member -
INFLARX N.V. Director/Board Member -
Director/Board Member -
See the detail of Li Na Ma's experience

Training of Li Na Ma

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

33

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies11

Health Technology

Consumer Services

Health Technology

Consumer Services

Health Technology

Health Technology

Finance

Beijing Defengrei Biotechnology Co. Ltd.

Commercial Services

Finance

Health Technology